Draft granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council
2022/2940(RSP)
The annual renewal of the conditional marketing authorisation for the medicinal product for human use "Veklury -
2022/2661(RSP)
Paxlovid Marketing Objection
2023/2604(RSP)